Home News

First nine months 2020 results presentation

Operating income, growth figures, profitability and how our products have behaved.

Thu, 05/11/2020 - 00:00 0 min
Download related document
No votes yet
 
Related
Incorporation of two doctors to the R&D&i within the "Torres...
0 min
30/10/2020
ROVI holds its 2020 General Shareholders' Meeting
ROVI holds its 2020 General Shareholders' Meeting
Today, Laboratorios Farmacéuticos Rovi, S.A. held its General Shareholders’ Meeting, where the year 2019, marked by significant growth, was...
5 min
20/10/2020
ROVI Rating ESG 2020
0 min
25/09/2020